Correlation Between Seer and Summit Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Seer and Summit Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seer and Summit Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seer Inc and Summit Therapeutics PLC, you can compare the effects of market volatilities on Seer and Summit Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seer with a short position of Summit Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seer and Summit Therapeutics.

Diversification Opportunities for Seer and Summit Therapeutics

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Seer and Summit is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Seer Inc and Summit Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Summit Therapeutics PLC and Seer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seer Inc are associated (or correlated) with Summit Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Summit Therapeutics PLC has no effect on the direction of Seer i.e., Seer and Summit Therapeutics go up and down completely randomly.

Pair Corralation between Seer and Summit Therapeutics

Given the investment horizon of 90 days Seer Inc is expected to under-perform the Summit Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Seer Inc is 3.51 times less risky than Summit Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Summit Therapeutics PLC is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  164.00  in Summit Therapeutics PLC on October 5, 2024 and sell it today you would earn a total of  1,685  from holding Summit Therapeutics PLC or generate 1027.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Seer Inc  vs.  Summit Therapeutics PLC

 Performance 
       Timeline  
Seer Inc 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Seer Inc are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady technical and fundamental indicators, Seer reported solid returns over the last few months and may actually be approaching a breakup point.
Summit Therapeutics PLC 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Summit Therapeutics PLC are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable primary indicators, Summit Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Seer and Summit Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Seer and Summit Therapeutics

The main advantage of trading using opposite Seer and Summit Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seer position performs unexpectedly, Summit Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Summit Therapeutics will offset losses from the drop in Summit Therapeutics' long position.
The idea behind Seer Inc and Summit Therapeutics PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume